Yunchao Huang
North China University of Water Resources and Electric Power(CN)Peking University(CN)Sichuan University(CN)Kunming Medical University(CN)West China Hospital of Sichuan University(CN)Second People's Hospital of Yunnan Province(CN)Peking University Cancer Hospital(CN)Affiliated Hospital of Youjiang Medical University for Nationalities(CN)Hangzhou DAC Biotech (China)(CN)Yunnan Provincial Infectious Disease Hospital(CN)Hubei Cancer Hospital(CN)
Publications by Year
Research Areas
Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Tracheal and airway disorders, Pleural and Pulmonary Diseases
Most-Cited Works
- → Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials(2015)1,573 cited
- → Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial(2020)492 cited
- → Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer(2024)291 cited
- → Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey(2018)133 cited
- → China national lung cancer screening guideline with low‐dose computed tomography (2015 version)(2015)88 cited